ArticleProceedings of the National Academy of Sciences of the United States of America2012

Variant Ciz1 is a circulating biomarker for early-stage lung cancer.

Gillian Higgins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.